RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/10327052http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/10327052http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/10327052http://www.w3.org/2000/01/rdf-schema#comment"Screening for surface molecules expressed by metastasizing rat tumors had revealed evidence for metastasis-association of a molecule also expressed on epithelial cells. The similarity to the expression profile of the panepithelial glycoprotein EGP314 prompted us to isolate and sequence the gene and to explore functional features of the molecule in transfected tumor lines. The molecule D5.7A, named according to the antibody, D5.7, used for selection, indeed, is the ortholog of EGP314 with 92% and 80% identity to the murine and the human molecules. Like EGP314, D5.7A has a particular cleavage site, a small cleavage product being resolved under reducing conditions from the membrane anchored part of the molecule. Transfection of a low metastasizing fibrosarcoma, pheochromoblastoma and adenocarcinoma revealed that expression of D5.7A facilitates tumor progression. Depending on the origin of the tumor, D5.7A transfectants either metastasized via the lymphatic system (pheochromoblastoma, adenocarcinoma) or hematogeneously (fibrosarcoma). Particularly after proteolytic cleavage, D5.7A facilitated cell - cell adhesion and provided a proliferative signal upon crosslinking. Thus, the rat ortholog of EGP314 is involved in metastasis formation. Importantly, its functional activities apparently rely on proteolytic cleavage. These findings provide a first evidence on how a panepithelial marker can be involved in tumor progression."xsd:string
http://purl.uniprot.org/citations/10327052http://purl.org/dc/terms/identifier"doi:10.1038/sj.onc.1202542"xsd:string
http://purl.uniprot.org/citations/10327052http://purl.org/dc/terms/identifier"doi:10.1038/sj.onc.1202542"xsd:string
http://purl.uniprot.org/citations/10327052http://purl.uniprot.org/core/author"Zoeller M."xsd:string
http://purl.uniprot.org/citations/10327052http://purl.uniprot.org/core/author"Zoeller M."xsd:string
http://purl.uniprot.org/citations/10327052http://purl.uniprot.org/core/author"Claas C."xsd:string
http://purl.uniprot.org/citations/10327052http://purl.uniprot.org/core/author"Claas C."xsd:string
http://purl.uniprot.org/citations/10327052http://purl.uniprot.org/core/author"Herlevsen M."xsd:string
http://purl.uniprot.org/citations/10327052http://purl.uniprot.org/core/author"Herlevsen M."xsd:string
http://purl.uniprot.org/citations/10327052http://purl.uniprot.org/core/author"Roesel M."xsd:string
http://purl.uniprot.org/citations/10327052http://purl.uniprot.org/core/author"Roesel M."xsd:string
http://purl.uniprot.org/citations/10327052http://purl.uniprot.org/core/author"Seiter S."xsd:string
http://purl.uniprot.org/citations/10327052http://purl.uniprot.org/core/author"Seiter S."xsd:string
http://purl.uniprot.org/citations/10327052http://purl.uniprot.org/core/author"Weth R."xsd:string
http://purl.uniprot.org/citations/10327052http://purl.uniprot.org/core/author"Weth R."xsd:string
http://purl.uniprot.org/citations/10327052http://purl.uniprot.org/core/author"Wuerfel J."xsd:string
http://purl.uniprot.org/citations/10327052http://purl.uniprot.org/core/author"Wuerfel J."xsd:string
http://purl.uniprot.org/citations/10327052http://purl.uniprot.org/core/date"1999"xsd:gYear
http://purl.uniprot.org/citations/10327052http://purl.uniprot.org/core/date"1999"xsd:gYear
http://purl.uniprot.org/citations/10327052http://purl.uniprot.org/core/name"Oncogene"xsd:string
http://purl.uniprot.org/citations/10327052http://purl.uniprot.org/core/name"Oncogene"xsd:string
http://purl.uniprot.org/citations/10327052http://purl.uniprot.org/core/pages"2323-2334"xsd:string
http://purl.uniprot.org/citations/10327052http://purl.uniprot.org/core/pages"2323-2334"xsd:string